Cell interactions in bone tissue engineering

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 1-2, 2010, Pages 93-102

  Pirraco, R P ^a   Marques, A P ^a   Reis, R L ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

Bone; Cell to cell interactions; Chondrocyte; Co cultures; Osteoblast; Osteoclast; Osteogenesis; Stem cells; Tissue engineering; Vascularization

Indexed keywords

BIOMATERIAL; TISSUE SCAFFOLD;

ANIMAL; BONE; BONE DEVELOPMENT; BONE REGENERATION; CELL COMMUNICATION; CELL CULTURE; COCULTURE; CULTURE TECHNIQUE; CYTOLOGY; FRACTURE HEALING; HUMAN; MACROPHAGE; METABOLISM; MONOCYTE; OSTEOCLAST; PHYSIOLOGY; REVIEW; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE REGENERATION; CELL COMMUNICATION; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COCULTURE TECHNIQUES; FRACTURE HEALING; HUMANS; MACROPHAGES; MONOCYTES; OSTEOCLASTS; OSTEOGENESIS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77951970008     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.01005.x     Document Type: Review

References (111)

1. Dawson JI, Oreffo ROC. Bridging the regeneration gap: stem cells, biomaterials and clinical translation in bone tissue engineering. Arch. Biochem. Biophys. 2008, 473:124-31.
2. Jordan KM, Sawyer S, Coakley P. The use of conventional and complementary treatments for knee osteoarthritis in the community. Rheumatology. 2004, 43:381-4.
3. Langer R, Vacanti JP. Tissue engineering. Science. 1993, 260:920-6.
4. Nerem RM, Sambanis A. Tissue engineering: from biology to biological substitutes. Tissue Eng. 1995, 1:3-13.
5. Salgado AJ, Coutinho OP, Reis RL. Bone tissue engineering: state of the art and future trends. Macromol. Biosci. 2004, 4:743-65.
6. Ackerman LV, Spjut HJ, Abell MR. Bones and joints 1976, Baltimore, MD, Williams and Wilkins
7. Baron R. General principles of bone biology 2003, 1-8. 5th ed., Washington, DC, American Society of Bone and Mineral Research, pp.
8. Hill PA, Orth M. Bone remodeling. J. Orthod. 1998, 25:101-7.
9. Sikavitsas VI, Temenoff JS, Mikos AG. Biomaterials and bone mechanotransduction. Biomaterials. 2001, 22:2581-93.
10. Aubin JE, Liu F. The osteoblast lineage. Principles of bone biology 1996, 51-68. Bilezikian JP RL, Rodan GA. In, editors, San Diego, Academic Press, pp
11. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science. 2000, 289:1501-4.
12. Mackie EJ. Osteoblasts: Novel roles in orchestration of skeletal architecture. Int. J. Biochem. Cell Biol. 2003, 35:1301-5.
13. Nijweide PJ, Burger EH, Nulend JK. The osteocyte. Principles of bone biology 1996, 115-26. Bilezikian JP RL, Rodan GA, In, editors, San Diego, Academic Press, pp.
14. Väänänen K. Osteoclast function: biology and mechanisms. Principles of bone biology 1996, Volume 1:127-40. Bilezikan JPRaisz LGRodan GA. In, editors, San Diego, Academic Press, pp.
15. Bennett JH, Moffatt S, Horton M. Cell adhesion molecules in human osteoblasts: structure and function. Histol. Histopathol. 2001, 16:603-11.
16. Marie PJ. Role of n-cadherin in bone formation. J. Cell. Physiol. 2002, 190:297-305.
17. Franceschi RT. The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit. Rev. Oral Biol. Med. 1999, 10:40-57.
18. Globus RK, Moursi A, Zimmerman D. Integrin-extracellular matrix interactions in connective tissue remodeling and osteoblast differentiation. ASGSB Bull.: Publ. Am. Soc. Gravit. Space Biol. 1995, 8:19.
19. Stains JP, Civitelli R. Cell-cell interactions in regulating osteogenesis and osteoblast function. Birth Defects Res. Part C: Embryo Today: Reviews. 2005, 75:72-80.
20. Kamioka H, Honjo T, Takano-Yamamoto T. A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy. Bone. 2001, 28:145-9.
21. Palumbo C, Palazzini S, Marotti G. Morphological study of intercellular junctions during osteocyte differentiation. Bone. 1990, 11:401-6.
22. Sasaki T, Hong MH, Udagawa N. Expression of vacuolar h+-atpase in osteoclasts and its role in resorption. Cell Tissue Res. 1994, 278:265-71.
23. Teitelbaum SL, Abu-Amer Y, Ross FP. Molecular mechanisms of bone resorption. J. Cell. Bioch. 1995, 59:1-10.
24. Teitelbaum SL, Tondravi MM, Ross FP. Osteoclasts, macrophages, and the molecular mechanisms of bone resorption. J. Leukoc. Biol. 1997, 61:381-8.
25. Frost HM. Intermediary organization of the skeleton 1986, Volume I and II. Boca Raton, CRC
26. Jee WS, Frost HM. Skeletal adaptations during growth. Triangle. 1992, 31:77-88.
27. Robling AG, Castillo AB, Turner CH. Biomechanical and molecular regulation of bone remodeling. Annu. Rev. Biomed. Eng 2006, 8:455.
28. Frost HM. Tetracycline-based histological analysis of bone remodeling. Calcif. Tissue Int. 1969, 3:211-37.
29. Matsuo K, Irie N. Osteoclast-osteoblast communication. Arch. Biochem. Biophys. 2008, 473:201-9.
30. Parfitt AM. Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone. 2002, 30:5-7.
31. Collin-Osdoby P. Role of vascular endothelial cells in bone biology. J. Cell. Biochem. 1994, 55:304-9.
32. Kanczler JM, Oreffo ROC. Osteogenesis and angiogenesis: the potential for engineering bone. Eur. Cells Mater. 2008, 15:100-14.
33. Streeten EA, Brandi ML. Biology of bone endothelial cells. Bone Miner. 1990, 10:85-94.
34. Parfitt AM. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J. Cell. Biochem. 1994, 55:273-86.
35. Parfitt AM. Skeletal heterogeneity and the purposes of bone remodeling: implications for the understanding of osteoporosis. Osteoporosis 2008, 315-29. Marcus R FDNelson DARosen CJ. In, editors, 2nd ed, San Diego, Academic Press, pp.
36. Parfitt AM. The mechanism of coupling: a role for the vasculature. Bone. 2000, 26:319-23.
37. Gerstenfeld LC, Barnes GL, Shea CM. Osteogenic differentiation is selectively promoted by morphogenetic signals from chondrocytes and synergized by a nutrient rich growth environment. Connect. Tissue Res. 2003, 44:85-91.
38. Gerstenfeld LC, Cruceta J, Shea CM. Chondrocytes provide morphogenic signals that selectively induce osteogenic differentiation of mesenchymal stem cells. J. Bone Miner. Res. 2002, 17:221-30.
39. Nurminskaya M, Magee C, Faverman L. Chondrocyte-derived transglutaminase promotes maturation of preosteoblasts in periosteal bone. Dev. Biol. 2003, 263:139-52.
40. Champagne CM, Takebe J, Offenbacher S. Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. Bone. 2002, 30:26-31.
41. Karadag A, Scutt AM, Croucher PI. Human myeloma cells promote the recruitment of osteoblast precursors: mediation by interleukin-6 and soluble interleukin-6 receptor. J. Bone Miner. Res. 2000, 15:1935-43.
42. Zhou J, Wu J, Tang R. Research in use of vascular endothelial cells to promote osteogenesis of marrow stromal cells. J. Biomed. Eng. 2003, 20:447-50.
43. Wang Y, Volloch V, Pindrus MA. Murine osteoblasts regulate mesenchymal stem cells via wnt and cadherin pathways: mechanism depends on cell-cell contact mode. J. Tissue Eng. Regenerat. Med. 2007, 1:39-50.
44. Buttery LDK, Bourne S, Xynos JD. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng. 2001, 7:89-99.
45. Hwang YS, Randle WL, Bielby RC. Enhanced derivation of osteogenic cells from murine embryonic stem cells after treatment with hepg2-conditioned medium and modulation of the embryoid body formation period: application to skeletal tissue engineering. Tissue Eng. 2006, 12:1381-92.
46. Declercq H, Van den Vreken N, De Maeyer E. Isolation, proliferation and differentiation of osteoblastic cells to study cell/biomaterial interactions: comparison of different isolation techniques and source. Biomaterials. 2004, 25:757-68.
47. Han D, Zhang Q. An essential requirement for osteoclasts in refined bone-like tissue reconstruction in vitro. Med. Hypotheses. 2006, 67:75-8.
48. Huang W, Carlsen B, Wulur I. Bmp-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and is required for in vitro bone formation in a PLGA scaffold. Exp. Cell Res. 2004, 299:325-34.
49. Folkman J, Hochberg M. Self-regulation of growth in three dimensions. J. Exp. Med. 1973, 138:745-53.
50. Kneser U, Kaufmann PM, Fiegel HC. Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matrices. J. Biomed. Mater. Res. 1999, 47:494-503.
51. Holy CE, Shoichet MS, Davies JE. Engineering three-dimensional bone tissue in vitro using biodegradable scaffolds: investigating initial cell-seeding density and culture period. J. Biomed. Mater. Res. 2000, 51:376-82.
52. Ishaug-Riley SL, Crane-Kruger GM, Yaszemski MJ. Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials. 1998, 19:1405-12.
53. Murphy WL, Simmons CA, Kaigler D. Bone regeneration via a mineral substrate and induced angiogenesis. J. Dent. Res. 2004, 83:204-10.
54. Pelissier P, Villars F, Mathoulin-Pelissier S. Influences of vascularization and osteogenic cells on heterotopic bone formation within a madreporic ceramic in rats. Plast. Reconstr. Surg. 2003, 111:1932-41.
55. Orban JM, Marra KG, Hollinger JO. Composition options for tissue-engineered bone. Tissue Eng. 2002, 8:529-39.
56. Santos MI, Unger RE, Sousa RA. Crosstalk between osteoblasts and endothelial cells co-cultured on a polycaprolactone-starch scaffold and the in vitro development of vascularization. Biomaterials. 2009, 30:4407-15.
57. Mikos AG, Herring SW, Ochareon P. Engineering complex tissues. Tissue Eng. 2006, 12:3307-39.
58. Mooney DJ, Mikos AG. Growing new organs. Sci. Am. 1999, 280:60-7.
59. Santos MI, Tuzlakoglu K, Fuchs S. Endothelial cell colonization and angiogenic potential of combined nano-and micro-fibrous scaffolds for bone tissue engineering. Biomaterials. 2008, 29:4306-13.
60. Brighton CT. Early histological and ultrastructural changes in medullary fracture callus. J. Bone Joint Surg. Am. 1991, 73:832-47.
61. Decker B, Bartels H, Decker S. Relationships between endothelial cells, pericytes, and osteoblasts during bone formation in the sheep femur following implantation of tricalciumphosphate-ceramic. Anat. Rec. 1995, 242:310-20.
62. Guenther HL. Endothelial cells in culture synthesize a potent bone cell active mitogen. Endocrinology. 1986, 119:193-201.
63. Jones AR, Clark CC, Brighton CT. Microvessel endothelial cells and pericytes increase proliferation and repress osteoblast phenotypic markers in rat calvarial bone cell cultures. J. Orthop. Res. 1995, 13:553-61.
64. Pechak DG, Kujawa MJ, Caplan AI. Morphological and histochemical events during first bone formation in embryonic chick limbs. Bone. 1986, 7:441-58.
65. Villanueva JE, Nimni ME. Promotion of calvarial cell osteogenesis by endothelial cells. J. Bone Miner. Res. 1990, 5:733-9.
66. Villars F, Bordenave L, Bareille R. Effect of human endothelial cells on human bone marrow stromal cell phenotype: Role of vegf. J. Cell. Biochem. 2000, 79:672-85.
67. Villars F, Guillotin B, Amedee T. Effect of huvec on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am. J. Physiol. Cell Physiol. 2002, 282:775-85.
68. Guillotin B, Bourget C, Remy-Zolgadri M. Human primary endothelial cells stimulate human osteoprogenitor cell differentiation. Cell Physiol. Biochem. 2004, 14:325-32.
69. Thomas Meury, Sophie Verrier, Alini M. Human endothelial cells inhibit bmsc differentiation into mature osteoblasts in vitro by interfering with osterix expression. J. Cell. Biochem. 2006, 98:992-1006.
70. Bai S, Kopan R, Zou W. Notch1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. J. Biol. Chem. 2008, 283:6509-18.
71. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003, 423:337-42.
72. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis 1. Endocr. Rev. 2000, 21:115-37.
73. Theoleyre S, Wittrant Y, Tat SK. The molecular triad opg/rank/rankl: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 2004, 15:457-75.
74. Wada T, Nakashima T, Hiroshi N. Rankl-rank signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 2006, 12:17-25.
75. Dai XM, Zong XH, Akhter MP. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone. J. Bone Miner. Res. 2004, 19:1441-51.
76. Sakagami N, Amizuka N, Li M. Reduced osteoblastic population and defective mineralization in osteopetrotic (op/op) mice. Micron. 2005, 36:688-95.
77. Karsdal MA, Martin TJ, Bollerslev J. Are nonresorbing osteoclasts sources of bone anabolic activity. J. Bone Miner. Res. 2007, 22:487-94.
78. Karsdal MA, Neutzsky-Wulff AV, Dziegiel MH. Osteoclasts secrete non-bone derived signals that induce bone formation. Biochem. Biophys. Res. Commun. 2008, 366:483-8.
79. Zhao C, Irie N, Takada Y. Bidirectional ephrinb2-ephb4 signaling controls bone homeostasis. Cell Metab. 2006, 4:111-21.
80. Jiang J, Nicoll SB, Lu HH. Co-culture of osteoblasts and chondrocytes modulates cellular differentiation in vitro. Biochem. Biophys. Res. Commun. 2005, 338:762-70.
81. Polykandriotis E, Euler S, Arkudas A. Regression and persistence: remodelling in a tissue engineered axial vascular assembly. J. Cell. Mol. Med. 2009, 13:4166-75.
82. Arkudas A, Beier JP, Heidner K. Axial prevascularization of porous matrices using an arteriovenous loop promotes survival and differentiation of transplanted autologous osteoblasts. Tissue Eng. 2007, 13:1549-60.
83. Kneser U, Polykandriotis E, Ohnolz J. Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Eng. 2006, 12:1721-31.
84. Fuchs S, Hofmann A, Kirkpatrick CJ. Microvessel-like structures from outgrowth endothelial cells from human peripheral blood in 2-dimensional and 3-dimensional co-cultures with osteoblastic lineage cells. Tissue Eng. 2007, 13:2577-88.
85. Hofmann A, Ritz U, Verrier S. The effect of human osteoblasts on proliferation and neo-vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture on polyurethane scaffolds. Biomaterials. 2008, 29:4217-26.
86. Fuchs S, Ghanaati S, Orth C. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. Biomaterials. 2008, 30:526-34.
87. Rouwkema J, Boer JD, Blitterswijk CAV. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng. 2006, 12:2685-93.
88. Stahl A, Wu X, Wenger A. Endothelial progenitor cell sprouting in spheroid cultures is resistant to inhibition by osteoblasts: a model for bone replacement grafts. FEBS Lett. 2005, 579:5338-42.
89. Unger RE, Sartoris A, Peters K. Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials. Biomaterials. 2007, 28:3965-76.
90. Wenger A, Stahl A, Weber H. Modulation of in vitro angiogenesis in a three-dimensional spheroidal coculture model for bone tissue engineering. Tissue Eng. 2004, 10:1536-47.
91. Kyriakidou K, Lucarini G, Zizzi A. Dynamic co-seeding of osteoblast and endothelial cells on 3D polycaprolactone scaffolds for enhanced bone tissue engineering. J. Bioact. Compat. Pol. 2008, 23:227-43.
92. Yu H, VandeVord PJ, Mao L. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization. Biomaterials. 2008, 30:508-17.
93. Yu H, VandeVord PJ, Gong W. Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells. J. Orthop. Res. 2008, 26:1147-52.
94. Kaigler D, Krebsbach PH, Wang Z. Transplanted endothelial cells enhance orthotopic bone regeneration. J. Dent. Res 2006, 85:633.
95. Kaigler D, Krebsbach PH, West ER. Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J. 2005, 19:665-7.
96. Crawford DC, Safran MR. Osteochondritis dissecans of the knee. J. Am. Acad. Orthop. Surg. 2006, 14:90-100.
97. Mano JF, Reis RL. Osteochondral defects: present situation and tissue engineering approaches. J. Tissue Eng. Regenerat. Med. 2007, 1:261-73.
98. Oliveira JM, Rodrigues MT, Silva SS. Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: scaffold design and its performance when seeded with goat bone marrow stromal cells. Biomaterials. 2006, 27:6123-37.
99. Cao T, Ho KH, Teoh SH. Scaffold design and in vitro study of osteochondral coculture in a three-dimensional porous polycaprolactone scaffold fabricated by fused deposition modeling. Tissue Eng. 2003, 9:103-12.
100. Mahmoudifar N, Doran PM. Tissue engineering of human cartilage and osteochondral composites using recirculation bioreactors. Biomaterials. 2005, 26:7012-24.
101. Spalazzi JP, Dionisio KL, Jiang J. Osteoblast and chondrocyte interactions during coculture on scaffolds. IEEE Eng. Med. Biol. Mag. 2003, 22:27-34.
102. Drees P, Eckardt A, Gay RE. Mechanisms of disease: molecular insights into aseptic loosening of orthopedic implants. Nat. Clin. Pract. Rheumatol. 2007, 3:165-71.
103. Green TR, Fisher J, Matthews JB. Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles. J. Biomed. Mater. Res. 2000, 53:490-7.
104. Nakashima Y, Sun D, Trindade MCD. Signaling pathways for tumor necrosis factor-a and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro. J. Bone Joint Surg. 1999, 81:603-15.
105. Rodrigo A, Vallés G, Saldana L. Alumina particles influence the interactions of cocultured osteoblasts and macrophages. J. Orthop. Res. 2006, 24:46-54.
106. Vallés G, Gil-Garay E, Munuera L. Modulation of the cross-talk between macrophages and osteoblasts by titanium-based particles. Biomaterials. 2008, 29:2326-35.
107. Curran JM, Gallagher JA, Hunt JA. The inflammatory potential of biphasic calcium phosphate granules in osteoblast/ macrophage co-culture. Biomaterials. 2005, 26:5313-20.
108. Domaschke H, Gelinsky M, Burmeister B. In vitro ossification and remodeling of mineralized collagen i scaffolds. Tissue Eng. 2006, 12:949-58.
109. Nakagawa K, Abukawa H, Shin MY. Osteoclastogenesis on tissue-engineered bone. Tissue Eng. 2004, 10:93-100.
110. Kim S, Kim SS, Lee SH. In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly (d, l-lactic-co-glycolic acid)/hydroxyapatite composite scaffolds. Biomaterials. 2008, 29:1043-53.
111. Hutmacher DW, Horch RE, Loessner D. Translating tissue engineering technology platforms into cancer research. J. Cell. Mol. Med. 2009, 13:1417-27.